Dennis dedicates the episode to his late father Dennis J. Teehan Sr., who died of cancer, featuring his oncologist Dr. Erin DeRose from Beth Israel Needham Cancer Center. DeRose shares her path into oncology, her experience in community practice, and the “best of both worlds” model: intimate, accessible suburban care with strong links to Boston specialists, tumor boards, clinical trials, and second opinions. They discuss rising lung cancer in never-smokers, screening debates and risks of incidental findings, risk factors like secondhand smoke, occupational exposures, family history, and radon, and advances from targeted therapies (including EGFR) and immunotherapy, plus emerging approaches like CAR-T, bispecifics, and antibody-drug conjugates alongside concerns about cost and access. They critique direct-to-consumer cancer blood tests, discuss prognosis conversations, then cover news on rising US life expectancy, GLP-1 benefits versus insurer losses, AI in diagnosis, and ultra-processed carbs, ending with March Madness, St. Patrick’s Day, and Boston sports.

Topics

01:00 Episode Dedication

02:06 Dr. Erin DeRose Background

05:59 Needham Cancer Center

07:04 Best of Both Worlds

12:52 Lung Cancer Screening

17:21 Non Smoking Risk Factors

19:40 Targeted Therapy Breakthroughs

23:34 Future of Cancer Care

26:23 Access and Cost Questions

28:03 Blood Tests for Screening

30:59 Talking Prognosis Compassionately

34:43 Closing Thanks and Advocacy

35:14 Post Interview Reflections

35:44 Cancer Care Shoutout

36:42 Life Expectancy Rebound

40:18 GLP One Benefits Debate

41:09 Insurance Coverage Crunch

42:09 Ozempic Safety Reality

43:50 AI In The Clinic

46:25 Good Carbs Vs Bad

49:34 March Madness Talk

52:00 St Patricks Day Bits

53:33 Boston Sports Minute

57:44 Wrap Up And Thanks